Skip to main content
Clinical Trials/NCT03849781
NCT03849781
Unknown
Not Applicable

Enhanced Heart Rate Monitoring of Newborns After Birth and During Resuscitation

Helse Stavanger HF1 site in 1 country500 target enrollmentMarch 8, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Newborn Resuscitation
Sponsor
Helse Stavanger HF
Enrollment
500
Locations
1
Primary Endpoint
Proportion of cases with adherence to resuscitation guidelines in non-breathing newborns
Last Updated
6 years ago

Overview

Brief Summary

In a multicenter randomized controlled trial the investigators will evaluate the efficacy of the novel heart rate meter NeoBeat on ventilation performance and short-term outcomes compared to standard care in newborns in need of positive pressure ventilation to initiate spontaneous breathing after birth.

Detailed Description

Heart rate assessment immediately after birth in newborn infants is the most important clinical indicator to evaluate the status of a newborn, and critical to the correct guidance of resuscitation efforts. One of the knowledge gaps identified by the International Liason Committee on Resuscitation (ILCOR) is how best to assess ventilation during newborn resuscitation, and improved technology for rapid application of ECG. Laerdal Medical has developed a novel heart rate meter, NeoBeat, implementing ECG dry-electrodes in a snug-fit abdomen-shaped buckle for for rapid application on the newborn. In a multicenter randomized controlled trial the investigators will study the efficacy of NeoBeat on ventilation performance and short-term outcomes compared to standard care in newborns in need of positive pressure ventilation to initiate spontaneous respiration after birth.

Registry
clinicaltrials.gov
Start Date
March 8, 2019
End Date
July 1, 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Inborn, Gestational age ≥ 28 weeks, Multiples according to availability of equipment

Exclusion Criteria

  • Congenital malformations that interfere with the intervention, Non-consent

Outcomes

Primary Outcomes

Proportion of cases with adherence to resuscitation guidelines in non-breathing newborns

Time Frame: First minute after birth

Defined as initiation of PPV within on minute

Secondary Outcomes

  • Change in time for pulse oximeter saturation to reach stable values of ≥ 95% without oxygen supplementation(first hour of life)
  • Adequate Vt delivered during PPV(first hour of life)
  • Change in ventilation fraction(first hour of life)
  • Change in time from birth to a stable HR ≥100 and 120 bpm(first hour of life)
  • Change in total duration of PPV(first hour of life)
  • Change in time from birth to initiation of PPV(first 15 minutes of life)
  • Change in number of infants with Apgar score <7 at 5 and 10 minutes(first 10 minutes of life)
  • Change in NICU admission rate after resuscitation(first hour of life)

Study Sites (1)

Loading locations...

Similar Trials